The abstract, titled The TRPV1 antagonist ACD440 Gel as a tool in pain precision medicine, results of a post hoc analysis , will be presented at the international pain conference NeuPSIG 2025 by Märta ...

The abstract, titled The TRPV1 antagonist ACD440 Gel as a tool in pain precision medicine, results of a post hoc analysis , will be presented at the international pain conference NeuPSIG 2025 by ...

Martin Jönsson O Märta Segerdahl AlzeCure Pharma Attachments AlzeCure presents ACD440 at the NeuPSIG 2025 pain conference SOURCE: AlzeCure Pharma View the original press release on ACCESS Newswire ...

The granting of orphan drug status for ACD440, combined with the positive interaction and response we have received from the FDA regarding our preIND application for a pivotal phase II/III study, ...

Whether they renounced their status because they were forced to or because they chose to, many of these royals took themselves off (or out of line for) the throne ...

The abstract, titled The TRPV1 antagonist ACD440 Gel as a tool in pain precision medicine, results of a post hoc analysis , will be presented at the international pain conference NeuPSIG 2025 by ...

Royals Who Gave Up Their Titles, Abdicated Thrones or Stepped Back from Duties for Love, Scandal and More Whether they renounced their status because they were forced to or because they chose to ...

Image Attachments: Martin Jönsson O Märta Segerdahl AlzeCure Pharma Attachments AlzeCure's pain project ACD440 granted orphan drug status in the US by the FDA SOURCE: AlzeCure Pharma ...

Sweden is holding an election Sunday to elect lawmakers to the 349-seat Riksdag as well as to local offices across the nation of 10 million people.

Royals from around the world have stepped back from duties or given up their titles or the throne, be it for love, scandal or something in between.

View Märta Blomstedt and Matti Lampén’s artworks on artnet. Learn about the artist and find an in-depth biography, exhibitions, original artworks, the latest news, and sold auction prices.